Physician profile
Amy E Oneil
NPI 1104266881
$2,526.92
in general payments reported to CMS, 2019-2025
24 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $199 · 2021: $265 · 2022: $130 · 2023: $364 · 2024: $781 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $395.81 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $314.29 | 2021-2025 | Eluvia, Watchman Flx |
| Philips North America LLC | $163.17 | 2024 | (5044) Mcot |
| Shockwave Medical, INC | $161.40 | 2025 | |
| Abbott Laboratories | $149.66 | 2019-2025 | Aveir, Jot Dx |
| Penumbra, INC. | $141.90 | 2025 | Indigo System |
| Cardiovascular Systems INC. | $131.76 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.64 | 2023-2024 | Jardiance |
| Inari Medical, INC. | $125.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bracco Diagnostics INC. | $124.96 | 2019 | |
| Abiomed | $113.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $102.70 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $99.59 | 2019-2024 | Eliquis, Camzyos |
| Medtronic, INC. | $69.87 | 2023-2025 | Closurefast, Venaseal, Linq II |
| Pfizer INC. | $65.99 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | $47.17 | 2021-2023 | Arcalyst |
| Amryt Pharma Holdings Ltd | $45.32 | 2023 | Mycapssa |
| Kestra Medical Technology Services, INC. | $30.35 | 2023 | Assure Wcd |
| Terumo Medical Corporation | $24.10 | 2024 | Angio-Seal |
| Astrazeneca Pharmaceuticals Lp | $21.75 | 2023 | Farxiga |
| Cordis US Corp. | $19.93 | 2023 | Rain Sheath Transradial |
| Merck Sharp & Dohme LLC | $18.05 | 2024 | Verquvo |
| Astellas Pharma US INC | $17.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Oneil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.